Survival differences among women with de novo stage IV and relapsed breast cancer

Annals of Oncology

Volumn 21, Issue 11, 2010, Pages 2169-2174

  Dawood, S ^a,b   Broglio, K ^a   Ensor, J ^a   Hortobagyi, G N ^a   Giordano, S H ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b DUBAI HOSPITAL   (United Arab Emirates)

Author keywords

Breast cancer; De novo stage IV; Metastatic

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE INTERVAL; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY;

EID: 77958506736     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdq220     Document Type: Article

References (19)

1. Jemal A, Siegel R, Ward E et al. Cancer statistics, 2009. CA Cancer J Clin 2009; 59(4): 225-249.
2. Harris JR, Morrow M, Bonadonna G. Cancer of the breast. In De Vitta VT Jr, Hellman S, Rosenberg SA (eds) Cancer. Principles and Practice in Oncology, 4th edition. Philadelphia, PA: JB Lippincott 1993; 1264-1332.
3. Miller KD, Sledge GW Jr. The role of chemotherapy for metastatic breast cancer. Hematol Oncol Clin North Am 1999; 13: 415-434.
4. Norton L. Metastatic breast cancer: length and quality of life. N Engl J Med 1991; 325: 1370-1371.
5. Cardoso F, Di LA, Lohrisch C et al. Second and subsequent lines of chemotherapy for metastatic breast cancer: what did we learn in the last two decades? Ann Oncol 2002; 13: 197-207.
6. Beslija S, Bonneterre J, Burstein HJ et al. Third consensus on medical treatment of metastatic breast cancer. Ann Oncol 2009; 20(11): 1771-1785.
7. Dawood S, Broglio K, Gonzalez-Angulo AM et al. Trends in survival over the past two decades among white and black patients with newly diagnosed stage IV breast cancer. J Clin Oncol 2008; 26(30): 4891-4898.
8. Giordano SH, Buzdar AU, Smith TL et al. Is breast cancer survival improving? Cancer 2004; 100(1): 44-52.
9. Andre F, Slimane K, Bachelot T et al. Breast cancer with synchronous metastases: trends in survival during a 14-year period. J Clin Oncol 2004; 22(16): 3302-3308.
10. Largillier R, Ferrero JM, Doyen J et al. Prognostic factors in 1,038 women with metastatic breast cancer. Ann Oncol 2008; 19(12): 2012-2019.
11. Blanchard DK, Shetty PB, Hilsenbeck SG, Elledge RM. Association of surgery with improved survival in stage IV breast cancer patients. Ann Surg 2008; 247(5): 732-738.
12. Rao R, Feng L, Kuerer HM et al. Timing of surgical intervention for the intact primary in stage IV breast cancer patients. Ann Surg Oncol 2008; 15(6): 1696-1702.
13. Singletary SE, Allred C, Ashley P et al. Staging system for breast cancer: revisions for the 6th edition of the AJCC Cancer Staging Manual. Surg Clin North Am 2003; 83: 803-819.
14. Gunduz N, Fisher B, Saffer EA. Effect of surgical removal on the growth and kinetics of residual tumor. Cancer Res 1979; 39: 3861-3865.
15. Fisher B, Saffer EA, Rudock C et al. Presence of a growth-stimulating factor in serum following primary tumor removal in mice. Cancer Res 1989; 49: 1996-2001.
16. Slamon DJ, Leyland-Jones B, Shak S et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 2001; 344(11): 783-792.
17. Dawood S, Kristine B, Hortobagyi GN, Giordano S. Prognosis of women with stage IV breast cancer by HER2 status and trastuzumab treatment: an institutional based review. J Clin Oncol 2008; 26 (Suppl): (Abstr 1018).
18. Perou CM, Sorlie T, Eisen MB et al. Molecular portraits of human breast tumors. Nature 2000; 406: 747-752.
19. Sorlie T, Perou CM, Tibshirani R et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 2001; 98: 10869-10874.